<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04437082</url>
  </required_header>
  <id_info>
    <org_study_id>200-54611</org_study_id>
    <nct_id>NCT04437082</nct_id>
  </id_info>
  <brief_title>Performance Evaluation of OCT and OCT Angiography-based Ocular Measurements (Optical Coherence Tomography)</brief_title>
  <acronym>OCT</acronym>
  <official_title>Performance Evaluation of OCT and OCTA-based Ocular Measurements</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Optovue</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Optovue</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess performance of measurements of anatomical and vascular
      structures of the eye based on OCT and OCTA scans in normal subjects and eyes with pathology.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 1, 2020</start_date>
  <completion_date type="Anticipated">October 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Standard Deviation</measure>
    <time_frame>Day 1</time_frame>
    <description>measure of variance</description>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">155</enrollment>
  <condition>Normal Eyes and Ocular Pathology</condition>
  <arm_group>
    <arm_group_label>Normal</arm_group_label>
    <description>no pre-existing conditions</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Glaucoma</arm_group_label>
    <description>diagnosis of glaucoma</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Retina</arm_group_label>
    <description>diagnosis of retina pathology</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cornea</arm_group_label>
    <description>diagnosis of corneal condition</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>optical coherence tomography</intervention_name>
    <description>imaging structural and vascular features of the eye</description>
    <arm_group_label>Cornea</arm_group_label>
    <arm_group_label>Glaucoma</arm_group_label>
    <arm_group_label>Normal</arm_group_label>
    <arm_group_label>Retina</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Seeing eye doctor for routine or follow-up care
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Normal - No pre-existing conditions.

          -  Glaucoma - Diagnosis of glaucoma.

          -  Retina - Diagnosis of retinal pathology

          -  Cornea - Diagnosis of clinic condition.

        Exclusion Criteria:

        - Unable to complete required exams.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>AMA Eye Research Institute</name>
      <address>
        <city>Marysville</city>
        <state>Ohio</state>
        <zip>43030</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Ashley George</last_name>
      <phone>937-553-2000</phone>
      <email>ageorge@amaeyes.com</email>
    </contact>
    <investigator>
      <last_name>Charlotte Agnone, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 15, 2020</study_first_submitted>
  <study_first_submitted_qc>June 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 18, 2020</study_first_posted>
  <last_update_submitted>June 17, 2020</last_update_submitted>
  <last_update_submitted_qc>June 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

